Toxicological determinations are crucial to coroners' or medical examiners' judgments that drugs are significantly involved in a death. However, differences in laboratory procedures, thoroughness of screening, and limits of detection may result in artifactual differences in the toxicological results and the subsequent interpretations of them. To test this possibility, we conducted a toxicology proficiency-testing survey of nine collaborating laboratories. The results for the proficiency samples point out startling interlaboratory differences in accuracy and precision of detection of drugs. These observed variations in toxicological proficiency may introduce a significant source of error in drug-death statistics and in epidemiological deductions based on these statistics.
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A brief proficiency-testing
program was performed, to assist the National Institute on Drug Abuse in its efforts to improve the investigating and reporting of drug-related deaths in nine major U. S. Drug was not found.
mortem specimens; that a fictional history might lead as well as mislead; that clearly specified information was better than a history; and that manufactured specimens should render the assays less difficult because no metabolites or other interfering substances were present. Table   1 shows the results for Sample I, the albumin solution with added secobarbital, pentobarbital, and salicylic acid at a calculated concentration of 6.5, 6.0, and 400 mg/liter, respectively.
Results
Sample I was sent out as a general unknown.
The results of the assays were generally quite good for these three drugs. Only one false negative was reported.
Most of the laboratories assayed the barbiturates by gas-liquid chromatography, using a chloroform extraction at acidic or neutral pH values ranging from pH 3 to 7.5. Salicylate was assayed by ultraviolet spectrophotometry after chloroform extraction of the specimen at acidic pH values ranging from pH 1 to 6. The extraction pH within the range given did not seem to influence the quantitative results for either barbiturate or salicylate. In contrast to the one false negative reported for Sample I, reports on Sample II (urine), also sent out as a general unknown, showed 18 (33%) false negatives out of a possible 54 findings ( much lower than for the previous two samples (5.7 and 5.4 mg/liter). Fourteen (33%) false negatives were reported out of 42 possible findings; there were two false positives (tyrosine and isopropanol).
Only one laboratory identified and quantitated all the drugs in the sample. Sample IV (urine) was sent out with all the drugs in the mixture specified, to check the quantitative procedures by bypassing the screening procedures.
Four (6%) false negative findings out of 63 possible findings were reported-a significant improvement over the previous three samples for which false negatives averaged 29%. One false positive was reported (cocaine). Table 5 shows these results.
A preponderance of the gas-chromatographic method is again apparent for all classes of drugs in this sample. Theoretically, because all drugs were identified, there should have been no false negatives for Sample IV, but one laboratory either did not assay for these drugs or looked for them and could not find them. The other false negative is probably a clerical error, the typing of "cocaine"for "codeine."
The last sample sent out, Sample V (urine), contained only secobarbital, 6.5 mg/liter. The drug(s) in the vial were identified as barbiturates in the covering letter. No false negatives were reported, but two false positives were found (phenobarbital and glutethimide). The one result reported as 384 mg/liter is, we hope, a transcriptional error in its omission of the decimal point (Table  6 ). Both false positives were found by gas chromatography, with use of a chloroform extraction at acidic pH, conditions similar to those used for the true positives. 
Discussion
The major finding of this proficiency study was that the toxicological laboratories with which the nine medical examiners and coroners were associated varied considerably in the precision and accuracy with which they performed drug assays. Another important finding was that accuracy and precision of the quantitation increased greatly with the amount of information supplied to the analyst with each sample. Examination of Tables 2 and 3, tabulating the results of a urine sample sent as an unknown, and Table 5 , tabulating the results of a urine sample sent with all the drugs present identified, is sufficient to indicate the improvement. Tables  2 and 3 contain a large proportion of negative and unquantitated results (33% false negatives and 26% unquantitated findings), while Table 5 contains 6% false negatives and 5% unquantitated findings, clearly a great improvement.In the case of the unknown sample (Table   2 ), four laboratories failed to identify, and two others failed to quantitate, methadone; in the case of the known sample (Table 5) , all nine laboratories quantitated methadone.
Evidently all these laboratories have adequate instrumentation and methodologies to quantitate these drugs when they are known to be in the sample. This problem seems to lie more in screening for drugs and not in quantitating them. If one can improve the screening accuracy, perhaps the whole toxicological examination will improve. We must conclude at this point that, since there exists a wide interlaboratory variance in the detection, accuracy, and precision of toxicological analysis, this wide variance is probably reflected in the drug-death statistics and drug-death certification in these and other cities in the United States. Epidemiological considerations based on these drug-death statistics will need to be re-evaluated in this light. Finally, the collective evaluations of this toxicological quality-control survey by the toxicologists and forensic pathologists most directly involved in death investigation and certification definitely supported the continuation of some similar program of proficiency testing by a neutral organization or agency. All individuals concerned believed that improvement in the accuracy of mortality statistics for drug-related deaths would result.
